Back

Prognostic significance of addition of electrocardiographic findings to the MAGGIC heart failure risk score

17 April 2023 (17:10 - 17:19)
Organised by:
Congress Presentation Part of: Clinical - Non invasive Electrocardiography (ECG) EHRA Premium Access EHRA 2023

About the speaker

Photo
Doctor Omer Dogan

T.C. Ministry of Health, Istinye State Hospital, Istanbul (Turkiye)

6 More presentations in this session

Presentation thumbnail
Evolution of surface and endocavitary signals in patients with arrhythmogenic cardiomyopathy at 1 and 5 years
Doctor C. Martignani (Bologna, IT) Doctor A. Spadotto (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Left-to-right atrioventricular activation delay, a novel measure of AV-conduction, predicts clinical outcomes in non-LBBB patients
Miss A. Beierle (Nauen, DE)
Abstract Slides Video
Presentation thumbnail
Non-invasive electrocardiographic mapping using an endo-epicardial system based on extracellular potentials shows better accuracy for atrial arrhythmias than ventricular arrhythmias.
Doctor L. Parreira (Setubal, PT)
Abstract Slides Video
Presentation thumbnail
Machine learning approach on high risk treadmill exercise test to predict obstructive coronary artery disease by using P QRS and T waves features
Doctor L. Pay (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
Single-lead ECGs with wearable technology: diagnostic accuracy in patients with cardiovascular disease
Doctor A. Briosa E Gala (Bern, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Clinical - Non invasive
Video

The Event

Event poster

EHRA 2023

17 April 2023 17:10 CET
You may be interested in
thumbnail
Congress Presentation
Predicting survival in patients with severe heart failure: risk scores validation in the HELP-HF cohort
thumbnail
Congress Presentation
Validation of electrocardiographic artificial intelligence model for outcome prediction in patients with heart failure
thumbnail
Congress Presentation
Role of mitral regurgitation in a new predictive model for mortality and hospitalization risk in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources